Evidence map›Paper›PMID 41701270›Full record

ArticleJournal of biomolecular NMR2026

Adarshi P Welegedara, Yi Jiun Tan, Matteo Borgini, Peter Wipf, Gottfried Otting

Abstract read
In one paragraph

Article in Journal of biomolecular NMR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Synthesis and In Vivo Incorporation of 4-Difluoromethyl-L-Phenylalanine Into Proteins.Chembiochem : a European journal of chemical biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adarshi P WelegedaraARC Centre of Excellence for Innovations in Peptide & Protein Science, Research School of Chemistry, Australian National University, Canberra, ACT, 2601, Australia.
Yi Jiun TanARC Centre of Excellence for Innovations in Peptide & Protein Science, Research School of Chemistry, Australian National University, Canberra, ACT, 2601, Australia.
Matteo BorginiDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Peter WipfDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Gottfried OttingARC Centre of Excellence for Innovations in Peptide & Protein Science, Research School of Chemistry, Australian National University, Canberra, ACT, 2601, Australia. Gottfried.otting@anu.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The R3H domain of the human protein Sµbp-2 was produced with 5-fluoro-L-isoleucine (FIle) and 5,5-difluoro-L-isoleucine (diFIle) as probes for detection by 19F-NMR spectroscopy. The fluorinated protein, produced by cell-free protein synthesis, was obtained more easily with diFIle than FIle as FIle readily hydrolysed at pH 7.5 with the release of fluoride. The 19F-NMR spectra showed large chemical shift ranges but were heterogeneous. The heterogeneities arose from difficulties to fully exclude canonical isoleucine, the presence of multiple conformations and limited stability of the proteins, with the sample made with diFIle being particularly prone to precipitation. 19F resonance assignments were obtained by comparison of the chemical shifts of γ1-protons with those observed in the wild-type protein. Non-uniform cross-peak intensities observed in short-delay 1H,19F correlation experiments suggest incomplete averaging of 3JHF couplings and therefore preferential rotamer populations of the CH2F and CHF2 groups.

Indexed as

FluorineIsoleucineNuclear Magnetic Resonance, BiomolecularHalogenationHumansFluorineIsoleucine19F-NMR spectroscopyCH2F groupCHF2 groupDifluoroisoleucineFluoroisoleucineR3H domain

Identifiers

PMID41701270
PMCPMC12913250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.